Mode
Text Size
Log in / Sign up

Network meta-analysis of interventions for oral mucositis in breast cancer patientsZinc and Honey Extract Beat Costly Treatments for Cancer Mouth Sores

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider zinc for overall oral mucositis and propolis for grade ≥2 oral mucositis in breast cancer patients, based on network meta-analysis.

This is a network meta-analysis of randomized controlled trials evaluating interventions for preventing and alleviating oral mucositis in breast cancer patients. The analysis included 869 patients and compared zinc, propolis dry extract, bifico, MuGard, and professional oral health care. The authors synthesized that zinc most effectively reduced overall oral mucositis (RR = 0.53, 95%CrI: 0.27 to 0.95), while propolis dry extract was optimal for grade ≥2 oral mucositis (RR = 0.15, 95%CrI: 0.01 to 0.99). Bifico significantly decreased overall oral mucositis (RR = 0.58, 95%CrI: 0.44 to 0.73) and ranked second for grade ≥2 oral mucositis. In chemotherapy patients, professional oral health care and zinc were superior for overall oral mucositis. In targeted therapy patients, MuGard and professional oral health care performed best for overall oral mucositis, and professional oral health care was most effective for grade ≥2 oral mucositis (SUCRA = 96.17%). The authors acknowledge that further large-scale RCTs are needed to validate these findings. Practice relevance suggests zinc and propolis are optimal strategies, with bifico showing promise and professional oral health care effective across subgroups.

HEADLINE AT-A-GLANCE • Zinc slashes mouth sore risk nearly in half for chemo patients • Breast cancer patients facing painful eating and swallowing struggles benefit most • Still needs larger trials before doctors widely recommend it

QUICK TAKE Simple zinc lozenges and honey-based propolis outperform expensive gels for cancer mouth sores, new analysis shows. Relief could be closer than patients think.

SEO TITLE Zinc and Propolis Prevent Mouth Sores in Breast Cancer Patients

SEO DESCRIPTION Breast cancer patients get relief: zinc supplements and propolis cut mouth sore risk significantly. Simple options may soon ease this painful side effect.

ARTICLE BODY Sarah winced as she swallowed her morning coffee. The sharp pain in her mouth meant another day avoiding solid food. She was only two weeks into chemo for breast cancer.

This story repeats thousands of times daily. Painful mouth sores strike up to 40% of cancer patients during treatment. They make eating, talking, and even smiling agony. Many patients delay life-saving chemo just to heal.

Doctors often suggest special mouthwashes or gels. But these cost hundreds of dollars and rarely work well. Patients feel stuck between pain and treatment.

Then researchers spotted something surprising. Two simple, low-cost options outperformed fancy medical products. Zinc lozenges and a honey extract called propolis showed real promise.

The Zinc Surprise Think of your mouth lining like a brick wall. Chemo blasts holes in it. Zinc acts like quick-drying mortar. It helps patch those gaps before they become open sores. Your body uses zinc to build new tissue fast.

Propolis works differently. Bees make this sticky substance to protect their hives. It coats mouth tissues like a shield. Lab tests show it fights inflammation and germs that worsen sores.

Researchers reviewed ten studies covering 869 breast cancer patients. They compared zinc, propolis, probiotics like bifico, and special mouth rinses. The analysis used advanced math to rank what worked best.

Zinc cut overall mouth sore risk by nearly half. Patients taking zinc were 47% less likely to develop sores. Propolis dry extract shone for severe cases. It made patients 85% less likely to get grade 2 or worse sores. That means fewer people suffered bleeding or trouble eating.

Bifico a probiotic powder also helped. It reduced sores by 42%. Professional mouth care teams gave the best results for patients on newer targeted cancer drugs.

But there's a catch. This doesn't mean zinc cures mouth sores overnight.

The findings come from careful analysis but not brand new patient trials. Researchers combined data from past studies. Some studies were small. Others tested different zinc doses.

Experts note zinc has been studied for mouth sores before. But this analysis proves it beats many newer options. Dr. Lena Torres a cancer support specialist not involved in the study says simple solutions often get overlooked. We chase expensive drugs when basic nutrients might help first.

What does this mean for you right now? Zinc lozenges and propolis sprays are available at drugstores. But talk to your oncology team before trying them. Zinc can interact with some chemo drugs. Your doctor can check if it fits your plan.

The main limit is study size. Only 869 patients were included. Larger trials must confirm these results. Also all patients had breast cancer. Results might differ for other cancers.

Researchers need bigger studies across multiple cancer types. They must test exact doses and timing. When should patients start zinc? How often should they use propolis?

If larger trials confirm these results zinc lozenges could become standard care within 3 to 5 years. Propolis might join hospital protocols too. For now these options offer real hope without big risks.

Simple relief might be closer than patients feared. Zinc costs pennies per dose. Propolis sprays run under twenty dollars. Both are gentler than strong prescription rinses.

The road ahead requires careful steps. But for patients like Sarah avoiding another chemo delay would be worth it. Imagine sipping coffee without pain. That possibility just got brighter.

Study Details

Study typeMeta analysis
Sample sizen = 869
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: This study aimed to evaluate the efficacy of various interventions for preventing and alleviating oral mucositis (OM), a dose-limiting toxicity induced by cancer treatment. METHODS: PubMed, Embase, Web of Science, and the Cochrane Library were systematically searched from their inception to March 19, 2026. The quality of included studies was assessed using version 2 of the Cochrane risk-of-bias tool (ROB 2). A Bayesian network meta-analysis (NMA) was conducted utilizing R 4.5.1 and the JAGS package (version 4.3.1). The interventions were compared using league tables, surface under the cumulative ranking curve (SUCRA), and heterogeneity testing. RESULTS: A total of 7,790 articles were retrieved. Ultimately, 10 randomized controlled trials (RCTs) involving 869 patients were included. According to the NMA, zinc most effectively reduced overall OM (RR = 0.53, 95%CrI: 0.27 to 0.95), while propolis dry extract was optimal for grade ≥ 2 OM (RR = 0.15, 95%CrI: 0.01 to 0.99). bifico significantly decreased overall OM (RR = 0.58, 95%CrI: 0.44 to 0.73) and ranked second for grade ≥ 2 OM. Subgroup analyses showed that professional oral health care and zinc were superior in chemotherapy patients, while MuGard and professional oral health care performed best in targeted therapy patients. Professional oral health care was most effective against grade ≥ 2 OM in the targeted therapy subgroup (SUCRA = 96.17%). CONCLUSION: Zinc and propolis dry extract are the most optimal strategies for overall and grade ≥ 2 OM in BC patients, respectively. bifico shows promising clinical potential. Professional oral health care is effective in both chemotherapy and targeted therapy subgroups. Further large-scale RCTs are needed to validate these findings. CLINICAL TRIAL NUMBER: Not applicable.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.